Aikido pharma reports filing for expanded worldwide patent coverage on key assets

New york, dec. 14, 2021 /prnewswire/ -- aikido pharma inc. (nasdaq: aiki) ("aikido" or the "company") today provided a status update on its expansion of key patent applications into several major ex-us territories worldwide. for the company's pancreatic cancer drug licensed from the university texas at austin, in which the company currently seeks patent protection in the us, the company will now also seek protection on the licensed drug formulation in china, india and the european patent office, with all member countries designated, which includes all 27 eu member countries plus 11 non-eu countries.
DOMH Ratings Summary
DOMH Quant Ranking